CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

FGFR2 fusion / rearrangement

Gene: FGFR2 · Type: fusion

Indications: Cholangiocarcinoma

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
PemigatinibCholangiocarcinomaINDICATED
FDA Label
Label
InfigratinibCholangiocarcinomaINDICATED
FDA Label
Label
FutibatinibCholangiocarcinomaINDICATED
FDA Label
Label